Total Payments
$400.68
2024 Payments
$221.38
Companies
12
Transactions
17
Medicare Patients
3,920
Medicare Billing
$446,967
Payment Breakdown by Category
Food & Beverage$278.91 (69.6%)
Education$121.77 (30.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $278.91 | 13 | 69.6% |
| Education | $121.77 | 4 | 30.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $106.43 | 2 | $0 (2023) |
| Merck Sharp & Dohme LLC | $57.54 | 3 | $0 (2024) |
| Lilly USA, LLC | $45.67 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $42.43 | 2 | $0 (2024) |
| SOBI, INC | $31.98 | 1 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $22.36 | 1 | $0 (2024) |
| Genentech USA, Inc. | $19.38 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $18.75 | 1 | $0 (2023) |
| Masimo Corporation | $17.34 | 1 | $0 (2023) |
| Daiichi Sankyo Inc. | $14.59 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $221.38 | 10 | Merck Sharp & Dohme LLC ($57.54) |
| 2023 | $142.52 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($106.43) |
| 2021 | $11.92 | 1 | Gilead Sciences, Inc. ($11.92) |
| 2018 | $24.86 | 2 | AstraZeneca Pharmaceuticals LP ($12.57) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/21/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: ONCOLOGY | ||||||
| 07/17/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Oncology | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | LUTATHERA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Oncology | ||||||
| 06/12/2024 | SOBI, INC | DOPTELET (Drug) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/15/2024 | Genentech USA, Inc. | Lunsumio (Biological), Polivy | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: BioOncology | ||||||
| 04/22/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: ONCOLOGY | ||||||
| 04/17/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: ONCOLOGY | ||||||
| 04/08/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Oncology | ||||||
| 03/26/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Iron Deficiency Anemia | ||||||
| 03/25/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $29.07 | General |
| Category: Oncology | ||||||
| 09/08/2023 | Masimo Corporation | Patient SafetyNet System (Device), SET and rainbow SET | Food and Beverage | In-kind items and services | $17.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | — | Education | In-kind items and services | $84.99 | General |
| 08/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ICLUSIG (Drug) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: ONCOLOGY | ||||||
| 03/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 05/31/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 02/27/2018 | AstraZeneca Pharmaceuticals LP | — | Education | In-kind items and services | $12.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 560 | 1,005 | $315,861 | $74,677 |
| 2022 | 8 | 664 | 1,175 | $310,738 | $87,826 |
| 2021 | 7 | 747 | 1,215 | $331,556 | $96,069 |
| 2020 | 32 | 1,949 | 23,635 | $869,298 | $188,395 |
Total Patients
3,920
Total Services
27,030
Medicare Billing
$446,967
Procedure Codes
72
All Medicare Procedures & Services
72 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 180 | 387 | $112,617 | $26,863 | 23.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 171 | 339 | $98,649 | $22,962 | 23.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 41 | 67 | $29,392 | $7,142 | 24.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 31 | 58 | $24,892 | $6,336 | 25.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 25 | $7,075 | $2,314 | 32.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 21 | 21 | $10,012 | $1,879 | 18.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $8,006 | $1,683 | 21.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 34 | 39 | $7,296 | $1,537 | 21.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $7,616 | $1,467 | 19.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 28 | $5,242 | $1,281 | 24.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $5,064 | $1,213 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 190 | 416 | $99,640 | $29,858 | 30.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 192 | 397 | $95,213 | $27,547 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 29 | 50 | $17,585 | $5,300 | 30.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 32 | 42 | $14,266 | $4,412 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 76 | $12,298 | $3,021 | 24.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 45 | 56 | $8,993 | $2,763 | 30.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 33 | $7,788 | $2,640 | 33.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 20 | 20 | $12,171 | $2,355 | 19.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 17 | 17 | $10,472 | $2,309 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 20 | 20 | $9,410 | $2,125 | 22.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $7,514 | $2,018 | 26.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 17 | $7,174 | $1,798 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 18 | 18 | $8,214 | $1,680 | 20.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 195 | 396 | $91,080 | $27,617 | 30.3% |
About Dr. Justin Markow, DO
Dr. Justin Markow, DO is a Medical Oncology healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/13/2012. The National Provider Identifier (NPI) number assigned to this provider is 1336414168.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Justin Markow, DO has received a total of $400.68 in payments from pharmaceutical and medical device companies, with $221.38 received in 2024. These payments were reported across 17 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($278.91).
As a Medicare-enrolled provider, Markow has provided services to 3,920 Medicare beneficiaries, totaling 27,030 services with total Medicare billing of $446,967. Data is available for 4 years (2020–2023), covering 72 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Hematology & Oncology
- Location Wilmington, NC
- Active Since 03/13/2012
- Last Updated 01/24/2025
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1336414168
Products in Payments
- KEYTRUDA (Biological) $57.54
- VERZENIO (Drug) $45.67
- DOPTELET (Drug) $31.98
- IMFINZI (Biological) $29.86
- LUTATHERA (Drug) $22.36
- ICLUSIG (Drug) $21.44
- Lunsumio (Biological) $19.38
- ERLEADA (Drug) $18.75
- Patient SafetyNet System (Device) $17.34
- INJECTAFER (Drug) $14.59
- ADCETRIS (Biological) $12.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Wilmington
Gerard Kennealey, Md, MD
Medical Oncology — Payments: $563,502
Medical Oncology $563,502
Andrew Schreiber, Md, MD
Medical Oncology — Payments: $545.81
Medical Oncology $545.81
Dr. Victor Sandor, Md, MD
Medical Oncology — Payments: $300.67
Medical Oncology $300.67
Douglas Testori, D.o, D.O
Medical Oncology — Payments: $45.32
Medical Oncology $45.32
William Mcnulty, Md, MD
Medical Oncology
Medical Oncology